The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


DPH DECHRA PHARMACEUTICALS PLC ORD 1P

DECHRA PHARM  Currency  GBX  Premium Equity Commercial Companies


Income Statement  (£ m) 30-Jun-13 30-Jun-12 30-Jun-11 30-Jun-10 30-Jun-09
Continuing Operations
Revenue  189.18 124.33 389.24 369.37 349.96
Operating Profit/(Loss)  18.34 10.27 21.72 19.87 17.67
Net Interest  5.15 2.87 3.90 3.37 4.78
Profit Before Tax  12.48 6.11 18.51 17.73 16.10
Profit After Tax  10.85 3.91 14.13 13.16 11.30
Discontinued Operations
Profit After Tax  8.42 7.84 0.00 0.00 0.00
PROFIT FOR THE PERIOD  19.27 11.75 14.13 13.16 11.30
Attributable to:
Minority Interests  0.00 0.00 0.00 0.00 0.00
Equity Holders of Parent Company  19.27 11.75 14.13 13.16 11.30
 
Continuing EPS
Earnings per Share - Basic  12.47p 5.20p 21.33p 19.97p 17.27p
Earnings per Share - Diluted  12.39p 5.18p 21.26p 19.89p 17.13p
Earnings per Share - Adjusted  29.27p 21.35p 34.33p 29.50p 25.61p
Continuing and Discontinued EPS
Earnings per Share - Basic  20.59p 15.65p 21.33p 19.97p 17.27p
Earnings per Share - Diluted  20.45p 15.60p 21.26p 19.89p 17.13p
Earnings per Share - Adjusted  38.98p 32.37p 34.33p 29.50p 25.61p
 
Dividend per Share  12.84p 12.50p 10.90p 9.40p 8.50p

Balance Sheet  (£ m) 30-Jun-13 30-Jun-12 30-Jun-11 30-Jun-10 30-Jun-09
Assets
Non-Current Assets
Property, Plant & Equipment  16.07 16.72 7.72 7.67 8.04
Intangible Assets  219.60 225.87 125.10 80.37 89.57
Investment Properties  0.00 0.00 0.00 0.00 0.00
Investments  0.00 0.00 0.00 0.00 0.00
Other Financial Assets  0.00 0.00 0.00 0.00 0.00
Other Non-Current Assets  0.00 0.00 0.00 0.00 0.00
  235.67 242.59 132.82 88.04 97.61
Current Assets
Inventories  29.20 57.28 40.76 34.82 31.53
Trade & Other Receivables  27.68 72.11 66.29 51.16 47.72
Cash at Bank & in Hand  32.79 32.44 30.50 31.50 26.82
Current Asset Investments  0.00 0.00 0.00 0.00 0.00
Other Current Assets  89.78 0.00 0.00 0.00 0.00
  179.46 161.83 137.55 117.48 106.07
 
Total Assets  415.13 404.42 270.37 205.53 203.67
 
Liabilities
Current Liabilities
Borrowings  -10.25 -5.11 -8.50 -20.44 -19.26
Other Current Liabilities  -93.77 -98.36 -80.45 -68.60 -66.46
  -104.02 -103.46 -88.95 -89.04 -85.72
 
Net Current Assets  75.44 58.37 48.60 28.44 20.35
 
Non-Current Liabilities
Borrowings  -103.34 -114.05 -56.09 -17.76 -23.08
Provisions  -27.18 -29.34 -13.44 -12.50 -14.18
Other Non-Current Liabilities  -5.97 -3.89 -13.56 0.00 0.00
  -136.49 -147.28 -83.08 -30.26 -37.27
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  -240.51 -250.74 -172.04 -119.30 -122.99
 
Net Assets  174.62 153.68 98.33 86.23 80.69
 
Capital & Reserves
Share Capital  0.87 0.87 0.66 0.66 0.66
Share Premium Account  123.49 122.64 63.56 63.02 62.44
Other Reserves  10.88 -2.20 6.23 2.83 5.75
Retained Earnings  39.38 32.37 27.88 19.71 11.84
Shareholders Funds  174.62 153.68 98.33 86.23 80.69
 
Minority Interests/Other Equity  0.00 0.00 0.00 0.00 0.00
Total Equity  174.62 153.68 98.33 86.23 80.69

Ratios - based on IFRS 30-Jun-13 30-Jun-12 30-Jun-11 30-Jun-10 30-Jun-09
Continuing Operations
PE Ratio - Adjusted  23.57 22.76 14.30 13.05 16.49
PEG - Adjusted  0.64 -0.60 0.87 0.86 0.71
Earnings per Share Growth - Adjusted  37.10% -37.81% 16.37% 15.19% 23.07%
Dividend Cover  2.28 1.71 3.15 3.14 3.01
Revenue Per Share  217.42p 165.59p 587.50p 560.53p 534.85p
Pre-Tax Profit per Share  14.34p 8.14p 27.94p 26.91p 24.61p
Operating Margin  9.28% 7.17% 5.46% 5.44% 5.35%
Return on Capital Employed  18.21% 11.72% 43.72% 37.30% 43.82%
 
Continuing & Discontinued Operations
Dividend Yield  1.86% 2.57% 2.22% 2.44% 2.01%
Dividend per Share Growth  2.72% 14.68% 15.96% 10.59% 9.68%
Net Asset Value per Share (exc. Intangibles)  -51.61p -83.10p -40.28p 8.86p -13.54p
Net Gearing  46.27% 56.43% 34.67% 7.77% 19.24%

Data is provided by Morningstar


DECHRA PHARM share - fundamentals

The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds